Immunocore Holdings

Immunocore Holdings

IMCR· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +17.7% in FY2025

Bahija Jallal, Ph.D. is the CEO of Immunocore Holdings and was paid $10.9M in FY2025 (Dec), down 15%.

Pay$100 in the stock at the end of FY21 → $101
CEO pay is from each Immunocore Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Bahija Jallal, Ph.D.FY2025
  2. 2Travis CoyFY2025
  3. 3David Berman, M.D., Ph.D.FY2025
  4. 4Tina St. LegerFY2024

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Immunocore Holdings paid its 3 named executives $20.3M in total in FY2025 (Dec). CEO Bahija Jallal, Ph.D. was paid $10.9M of that.

Name
Bahija Jallal, Ph.D.Chief Executive Officer
Travis CoyChief Financial OfficerNot disclosedNot disclosed
David Berman, M.D., Ph.D.Former Executive Vice President, Head of Research & Development
Tina St. LegerChief Human Resources OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers20

See all

The FY2025 (Dec) proxy of Immunocore Holdings names 20 peer companies for pay. Among Immunocore Holdings and these peers, CEO pay was 4th highest of 7 and total shareholder return was 4th highest of 7.

4th highest of 7in Immunocore Holdings and its pay peers, FY2025 (Dec) by CEO pay:

$5.8M$25.6M

4th highest of 7in Immunocore Holdings and its pay peers, FY2025 (Dec) by total shareholder return:

$23$247

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Roy S. Herbst, M.D., Ph.D.Director · 4 yr on the boardIndependent—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 16, 2026FY2025
Annual report10-KFeb 25, 2026FY2025
Proxy statementDEF 14AApr 4, 2025FY2024
Annual report10-KFeb 26, 2025FY2024
Proxy statementDEF 14AApr 12, 2024FY2023
Annual report10-KFeb 28, 2024FY2023